LEUCOENCEFALOPATIA MULTIFOCAL PROGRESSIVA PDF

Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva. Abstract. PASQUALOTTO, Alessandro Comarú; MATTOS, Alice J.Z. de and ROCHA, Marineide Melo. Leucoencefalopatia multifocal progressiva confirmada por. A leucoencefalopatia multifocal progressiva (LMP) é uma doença desmielinizante do sistema nervoso central (SNC) causada pela reativação do vírus JC (JCV).

Author: Kikasa Tojinn
Country: Uganda
Language: English (Spanish)
Genre: Sex
Published (Last): 1 April 2012
Pages: 68
PDF File Size: 15.89 Mb
ePub File Size: 13.45 Mb
ISBN: 305-6-26842-139-3
Downloads: 61553
Price: Free* [*Free Regsitration Required]
Uploader: Kazishakar

During a follow-up visit, he reported speech and visual difficulties. Subcortical frontal and parieto-occipital regions are common locations.

Progressive multifocal leukoencephalopathy: new concepts

Primary PML developing in an immunocompetent patient is very rare. Journal List Dement Neuropsychol v.

However, due to its biological properties, it remains active for as long as three months and during this period, PML can progress. Services on Prohressiva Journal. D Progressiba – Corticosteroids have been used by several groups in order to modulate inflammatory reaction and avoid a catastrophic deterioration, but their use is controversial since they can also potentiate immunosuppression and blunt the JCV specific cellular immune response The subcortical lesions tend to involve Leucoencefa,opatia.

However, JCV has mmultifocal also associated with other neurological diseases. Retrieved 25 September Unable to process the form. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients a report of 57 cases from the Research on Adverse Drug Events and Reports project.

  JACQUES DELORS LA EDUCACION ENCIERRA UN TESORO PDF

The breakdown of myelin is commensurate with the degree of immunocompromise. Improvement in immunosuppression seems to be beneficial and can lead to stabilization or regression of the disease in follow-up on imaging exams.

A characteristic imaging finding has recently been described by Bezuidenhout et al. J Neurovirol ;8 Suppl 2: Despite the support therapy, the patient evolved with clinical and radiological deterioration Figure 3.

Archived from the original on 4 January Case 6 Case 6. It is caused by the JC viruswhich is normally present and kept under control by the immune system.

Progressive multifocal leukoencephalopathy

The most frequently encountered symptoms include:. The introduction of more potent antiretroviral regimens led to a considerable decrease in its incidence and mortality in the last 17 years.

Rarely, there is involvement of the spinal cord. Some reports also state some benefit with cytarabine multiocal mirtazapine, the latter especially in natalizumab-associated PML.

It is caused by the reactivation lrucoencefalopatia the JC virus genus: Clin Dev Immunol ; This is an open-access article distributed under the terms of the Creative Commons Attribution License. T2-weighted MRI showing progressive multifocal leukoencephalopathy. The patient cleared the virus and had no further neurological deterioration.

  LIBRO 100 MEJORES ROCKAS PDF

J Am Acad Dermatol ; The presence of seizures, vertigo, headache and aphasia is less frequent.

PML is a demyelinating diseasein which the myelin sheath covering the axons of nerve cells is gradually destroyed, impairing the transmission of nerve impulses. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.

Restoration of the adaptive immune response is crucial in controlling JCV replication and stabilizing disease. Migraine Familial hemiplegic Cluster Tension. It refers to a coalescent bilateral parieto-occipital T2 and FLAIR hyperintense lesion with progressifa of the splenium of the corpus callosum reminiscent of a barbell see case. T1-weighted image post-contrast reveals cortical-subcortical hypointensity in left temporal lobe, without enhancement white arrow.

Most of the reported patients who developed IRIS received high-dose glucocorticoids dexamethasone or methylprednisolone followed by a slow tapering in order to lessen the immune reconstitution and avoid additional damage Patients with progressive multifocal leukoencephalopathy present with various neurological symptoms.

Progressive multifocal leukoencephalopathy in patients with HIV infection.